HCA
HCA Healthcare, Inc.
$429.29
장중 · Vol 31.2K · 52주 $353.99–$556.52 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $417.31 · Aug 31, 2026
HCA 가격 추세
종가
$417.31
시가
$423.76
고가
$419.33
저가
$415.00
30초 브리핑
HCA 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 37%
52주 범위 중간 구간으로 가격 위치만으로 방향성은 제한적입니다.
Forward P/E 12.9배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 2.7배
평소보다 거래가 활발해 가격 움직임의 확인 강도가 높습니다.
2026-10-23
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
HCA 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
One Park Plaza · Nashville, TN, United States · 직원 230,000명
시가총액
$89.73B
Trailing P/E
14.0
최근 12개월 이익 기준
Forward P/E
12.9
이익 증가 기대 반영
EPS (TTM)
$29.59
배당 수익률
0.75%
배당성향
10.1%
베타
1.11
시장과 유사
ROE
—
P/B
-13.60
EV/EBITDA
9.2
52주 범위
$353.99 – $556.52
현재 위치 37%
거래량
2.06M
20일 평균 757.2K · 2.7배
애널리스트 의견
매수 56%
총 25명 · 0m
DITM LEAPS Analysis
HCA 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HCA280121C00230000 | 1/21/28 · 1.4Y | $230.00 | $199.25 | 1.9x | 0.9133 | 7.4% | 2.26% | 52.57% | 5 | 77.30 | |
| HCA280121C00240000 | 1/21/28 · 1.4Y | $240.00 | $190.75 | 2.0x | 0.9048 | 8.6% | 2.36% | 51.28% | 5 | 75.85 | |
| HCA280121C00250000 | 1/21/28 · 1.4Y | $250.00 | $182.25 | 2.0x | 0.8961 | 9.8% | 2.47% | 49.94% | 15 | 75.46 | |
| HCA280121C00260000 | 1/21/28 · 1.4Y | $260.00 | $174.25 | 2.1x | 0.8857 | 11.4% | 2.58% | 49.03% | 2 | 71.50 | |
| HCA280121C00280000 | 1/21/28 · 1.4Y | $280.00 | $158.50 | 2.3x | 0.8640 | 15.2% | 2.52% | 46.95% | 18 | 69.70 | |
| HCA280121C00270000 | 1/21/28 · 1.4Y | $270.00 | $166.25 | 2.2x | 0.8751 | 13.1% | 2.71% | 48.03% | 1 | 68.83 | |
| HCA280121C00290000 | 1/21/28 · 1.4Y | $290.00 | $150.75 | 2.3x | 0.8515 | 17.4% | 2.99% | 46.20% | 13 | 66.84 | |
| HCA280121C00300000 | 1/21/28 · 1.4Y | $300.00 | $143.25 | 2.4x | 0.8386 | 20.1% | 3.14% | 45.36% | 21 | 64.73 | |
| HCA280121C00310000 | 1/21/28 · 1.4Y | $310.00 | $135.75 | 2.5x | 0.8253 | 23.1% | 3.31% | 44.43% | 13 | 61.55 | |
| HCA280121C00320000 | 1/21/28 · 1.4Y | $320.00 | $128.75 | 2.6x | 0.8107 | 26.6% | 3.50% | 43.77% | 4 | 57.19 | |
| HCA280121C00330000 | 1/21/28 · 1.4Y | $330.00 | $122.00 | 2.7x | 0.7957 | 30.8% | 3.28% | 43.01% | 22 | 55.60 | |
| HCA280121C00340000 | 1/21/28 · 1.4Y | $340.00 | $115.50 | 2.8x | 0.7795 | 35.5% | 3.46% | 42.48% | 12 | 51.15 | |
| HCA280121C00350000 | 1/21/28 · 1.4Y | $350.00 | $109.00 | 2.9x | 0.7630 | 40.9% | 3.67% | 41.85% | 26 | 47.86 |
재무제표
HCA 연간 손익·현금흐름·재무상태
매출 성장률
+7.1%
최근 연간 YoY
EPS 성장률
+28.8%
최근 연간 YoY
영업이익률
15.8%
최근 연간
FCF 마진
10.2%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $75.60B+7.1% | $70.60B+8.7% | $64.97B+7.9% | $60.23B |
| 매출총이익 | $31.37B+9.4% | $28.68B+12.1% | $25.58B+10.4% | $23.18B |
| 영업이익 | $11.96B+13.4% | $10.55B+9.6% | $9.63B+6.3% | $9.05B |
| 순이익 | $6.78B+17.8% | $5.76B+9.9% | $5.24B-7.1% | $5.64B |
| 희석 EPS | $28.33+28.8% | $22.00+16.0% | $18.97-0.9% | $19.15 |
| EBITDA | $15.60B+12.3% | $13.90B+9.2% | $12.72B-4.3% | $13.29B |
| 영업현금흐름 | $12.64B+20.2% | $10.51B+11.5% | $9.43B+10.7% | $8.52B |
| 잉여현금흐름 | $7.69B+36.4% | $5.64B+20.3% | $4.69B+13.6% | $4.13B |
| 총자산 | $60.72B+2.0% | $59.51B+5.9% | $56.21B+7.2% | $52.44B |
| 총부채 | $48.70B+7.6% | $45.24B+8.1% | $41.86B+4.1% | $40.20B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
HCA 실적·배당 일정
매출 하단
$18.80B
EPS 하단
$5.83
매출 상단
$19.87B
배당 지급일
2026-09-30
D-29
실적 발표일
2026-10-23
D-52
EPS 상단
$7.35
매출 컨센서스
$19.37B
EPS 컨센서스
$6.74
배당락일
2026-09-16
D-15
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| Jun 16, 2026 | $0.7800 |
| Mar 17, 2026 | $0.7800 |
| Dec 15, 2025 | $0.7200 |
| Sep 16, 2025 | $0.7200 |
| Jun 16, 2025 | $0.7200 |
| Mar 17, 2025 | $0.7200 |
| Dec 13, 2024 | $0.6600 |
| Sep 16, 2024 | $0.6600 |
뉴스
HCA 관련 최신 기사
실적Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
Zacks · Aug 28, 2026
제품·기술Do Wall Street Analysts Like HCA Healthcare Stock?
Despite trailing the broader market over the past year, HCA Healthcare continues to command a moderately optimistic outlook from Wall Street analysts, who see room for further upside in the stock.
Barchart · Aug 21, 2026
일반Universal Health Shares Drop 21% YTD: Should You Buy Now?
UHS' 21% YTD slide has cheapened its valuation, but weaker volumes, ACA pressure and lower growth forecasts keep risks elevated.
Zacks · Aug 20, 2026
- 실적
Palantir Stock Climbs as Enterprise AI Demand Keeps Growing
Palantir Stock Rises as Fresh AI Demand Keeps Post-Earnings Momentum Alive
GuruFocus.com · Aug 19, 2026
제품·기술1 Healthcare Stock with Exciting Potential and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 24.6% gain over the past six months, beating the S&P 500 by 11.4 percentage points.
StockStory · Aug 18, 2026
실적Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going?
THC's hospital growth is fueling earnings momentum as stronger volumes, revenues and margins help offset exchange weakness.
Zacks · Aug 17, 2026
- 일반
3 Reasons HCA Has Explosive Upside Potential
HCA Healthcare’s stock price has taken a beating over the past six months, shedding 24.5% of its value and falling to $404.01 per share. This might have investors contemplating their next move.
StockStory · Aug 17, 2026
실적Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
HCA Healthcare, Inc. (NYSE:HCA) reported its second-quarter 2026 financial results on July 24, confirming the figures previewed earlier in the month. While top-line growth remained healthy, a visible deterioration in payer mix and a revision to full-year profitability guidance triggered immediate target cuts across Wall Street. In its Q2 results, HCA Healthcare, Inc. reported that […]
Insider Monkey · Aug 13, 2026
실적What Could HCA Healthcare (HCA) Union Protests Mean For Pay And Staffing?
HCA Healthcare (NYSE:HCA) is facing nationwide union led protests as workers press for higher wages and improved staffing during ongoing contract negotiations. Union organizers say demonstrations span multiple HCA Healthcare facilities across the US and focus on pay, staffing ratios, and working conditions. The dispute centers on how HCA Healthcare allocates resources, including reported profits and share buybacks, relative to frontline labor costs and staffing levels. These protests...
Simply Wall St. · Aug 12, 2026
- 일반
HCA’s New Clinical and Ambulatory Structure: Strategic Tune-Up or Turning Point for HCA (HCA)?
HCA Healthcare has appointed Michael Schlosser, M.D., as executive vice president and chief clinical officer and created a new Ambulatory Operations Group led by Charles Gressle, consolidating oversight of clinical services, digital transformation, and more than 2,700 outpatient facilities as part of a broad leadership realignment that began taking effect in 2026. An interesting angle for investors is that Schlosser will simultaneously run HCA’s Clinical Services Group and its digital...
Simply Wall St. · Aug 12, 2026
홀더
HCA 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
78.9%
기관 보유 (유동주식)
94.7%
내부자 보유
16.6%
기관 수
1,867
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Blackrock Inc. | 13.00M | $5.39B | 6.0% | -2.7% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 10.14M | $4.20B | 4.7% | -0.4% | Jun 30, 2026 |
| Sanders Capital, LLC | 8.83M | $3.66B | 4.1% | -1.4% | Jun 30, 2026 |
| State Street Corporation | 7.47M | $3.10B | 3.5% | -0.9% | Jun 30, 2026 |
| Wellington Management Group, LLP | 4.71M | $1.95B | 2.2% | 20.5% | Jun 30, 2026 |
| Geode Capital Management, LLC | 3.67M | $1.52B | 1.7% | -0.7% | Jun 30, 2026 |
| First Eagle Investment Management, LLC | 3.30M | $1.37B | 1.5% | 1.3% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 2.71M | $1.12B | 1.3% | -1.6% | Jun 30, 2026 |
| Morgan Stanley | 2.59M | $1.07B | 1.2% | 12.7% | Jun 30, 2026 |
| Goldman Sachs Group Inc | 2.46M | $1.02B | 1.1% | 15.4% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.
![[일간 리포트] 2026년 매크로 전환점: AI 자본 지출의 역설과 미국 소비 절벽 분석(2026.02.11)](/_next/image?url=%2Fuploads%2F1770766346972_unnamed_(27).png&w=3840&q=75)
![[일간 리포트] 연준의 균열(10:2)과 AI Capex의 딜레마 (MSFT vs META)(2026.01.29)](/_next/image?url=%2Fuploads%2F1769642347461_unnamed_(19).png&w=3840&q=75)
![[일간 리포트]트럼프 관세 위기와 셧다운 우려, 그럼에도 기술주가 오르는 이유 (2026.01.28)](/_next/image?url=%2Fuploads%2F1769557597019_unnamed_(18).png&w=3840&q=75)